Dr. Jonathan Noujaim
Claim this profileGSK Investigational Site
Studies Tumors
Studies Breast Cancer
5 reported clinical trials
13 drugs studied
Area of expertise
1Tumors
Stage IV
HLA-A positive
NY-ESO-1 positive
2Breast Cancer
Stage IV
ER positive
Stage III
Affiliated Hospitals
Clinical Trials Jonathan Noujaim is currently running
Lasofoxifene and Abemaciclib vs Fulvestrant and Abemaciclib
for Breast Cancer
The goal of this clinical trial is to assess the efficacy, safety and tolerability of the combination of lasofoxifene and abemaciclib compared to fulvestrant and abemaciclib for the treatment of pre- and postmenopausal women and men who have previously received ribociclib or palbociclib-based treatment and have locally advanced or metastatic estrogen receptor positive (ER+)/human epidermal growth factor 2 negative (HER2-) breast cancer with an estrogen receptor 1 (ESR1) mutation. The main question the study aims to answer is: • To compare the efficacy of the combination of lasofoxifene and abemaciclib with that of fulvestrant and abemaciclib Participants will receive either receive 5 mg/d of oral lasofoxifene plus oral abemaciclib 150 mg twice a day or the combination of fulvestrant 500 mg intramuscular (IM) on Days 1, 15, and 29 and then once monthly thereafter plus oral abemaciclib 150 mg twice a day.
Recruiting2 awards Phase 312 criteria
Adoptive Cell Therapy
for Cancer
This trial will evaluate long term safety of participants who have received AdaptImmune (ADP) adoptive cell therapy for up to 15 years following last adoptive cell therapy infusion.
Recruiting1 award Phase 1
More about Jonathan Noujaim
Clinical Trial Related1 year of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Jonathan Noujaim has experience with
- Cyclophosphamide
- Fludarabine
- Lasofoxifene
- Abemaciclib
- Fulvestrant
- GSK Adoptive Cell Therapy
Breakdown of trials Jonathan Noujaim has run
Tumors
Leiomyosarcoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jonathan Noujaim specialize in?
Jonathan Noujaim focuses on Tumors and Breast Cancer. In particular, much of their work with Tumors has involved Stage IV patients, or patients who are HLA-A positive.
Is Jonathan Noujaim currently recruiting for clinical trials?
Yes, Jonathan Noujaim is currently recruiting for 2 clinical trials in Montreal Quebec. If you're interested in participating, you should apply.
Are there any treatments that Jonathan Noujaim has studied deeply?
Yes, Jonathan Noujaim has studied treatments such as Cyclophosphamide, Fludarabine, Lasofoxifene.
What is the best way to schedule an appointment with Jonathan Noujaim?
Apply for one of the trials that Jonathan Noujaim is conducting.
What is the office address of Jonathan Noujaim?
The office of Jonathan Noujaim is located at: GSK Investigational Site, Montreal, Quebec H1T 2M4 Canada. This is the address for their practice at the GSK Investigational Site.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.